O

OrbusNeich Medical Group Holdings Ltd
HKEX:6929

Watchlist Manager
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Watchlist
Price: 3.75 HKD -1.57%
Market Cap: 3.1B HKD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
OrbusNeich Medical Group Holdings Ltd

Wall Street analysts forecast OrbusNeich Medical Group Holdings Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 5.69 HKD with a low forecast of 4.75 HKD and a high forecast of 6.77 HKD.

Lowest Forecast
Wall Street Target
4.75 HKD
27% Upside
Average Forecast
Wall Street Target
5.69 HKD
52% Upside
Highest Forecast
Wall Street Target
6.77 HKD
81% Upside
Lowest
Price Target
4.75 HKD
27% Upside
Average
Price Target
5.69 HKD
52% Upside
Highest
Price Target
6.77 HKD
81% Upside
OrbusNeich Medical Group Holdings Ltd Competitors:
Price Targets
S
1501
Shanghai Kindly Medical Instruments Co Ltd
35% Upside
XVIVO
Xvivo Perfusion AB
55% Upside
ESTA
Establishment Labs Holdings Inc
53% Upside
688050
Eyebright Medical Technology Beijing Co Ltd
68% Upside
S
1501
Shanghai Kindly Medical Instruments Co Ltd
35% Upside
XVIVO
Xvivo Perfusion AB
55% Upside
ESTA
Establishment Labs Holdings Inc
53% Upside
688050
Eyebright Medical Technology Beijing Co Ltd
68% Upside
8086
Nipro Corp
20% Upside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
24% Upside
7730
Mani Inc
48% Upside
1066
Shandong Weigao Group Medical Polymer Co Ltd
14% Upside

Revenue
Forecast

Revenue Estimate
OrbusNeich Medical Group Holdings Ltd

For the last 3 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's revenue is 12%. The projected CAGR for the next 3 years is 10%.

12%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
OrbusNeich Medical Group Holdings Ltd

For the last 3 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's operating income is 17%. The projected CAGR for the next 3 years is 14%.

17%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
OrbusNeich Medical Group Holdings Ltd

The compound annual growth rate of OrbusNeich Medical Group Holdings Ltd's net income for the next 3 years is 27%.

N/A
Past Growth
27%
Estimated Growth
Estimates Accuracy
14%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OrbusNeich Medical Group Holdings Ltd's stock price target?
Price Target
5.69 HKD

According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 5.69 HKD with a low forecast of 4.75 HKD and a high forecast of 6.77 HKD.

What is OrbusNeich Medical Group Holdings Ltd's Revenue forecast?
Projected CAGR
10%

For the last 3 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's revenue is 12%. The projected CAGR for the next 3 years is 10%.

What is OrbusNeich Medical Group Holdings Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 3 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's operating income is 17%. The projected CAGR for the next 3 years is 14%.

What is OrbusNeich Medical Group Holdings Ltd's Net Income forecast?
Projected CAGR
27%

The compound annual growth rate of OrbusNeich Medical Group Holdings Ltd's net income for the next 3 years is 27%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 257,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.